WAVE Life Sciences (WVE) Tops Q3 EPS by 25c

WAVE Life Sciences (NASDAQ: WVE) reported Q3 EPS of $0.07, $0.25 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $49.2 million versus the consensus estimate of $23.43 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance